ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AGI AGI

7.25
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
AGI LSE:AGI London Ordinary Share IE00B0YT0Q82 ORD EUR0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.25 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

AGI Share Discussion Threads

Showing 826 to 849 of 875 messages
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older
DateSubjectAuthorDiscuss
09/1/2012
08:58
well thats a decent profit for me but i was prepared to wait for more.
m

maurillac
09/1/2012
08:04
Sold out for less than cash on the balance sheet cannot believe the rest of the buisness had a negative value.
wskill
09/1/2012
07:45
Great result, Happy with that
nico9
09/1/2012
07:21
wsa this one nobby was deramping 2 months ago??

what a koch

moreforus
09/1/2012
07:03
Offer for AGI Therapeutics plc
Print
Alert

TIDMAGI

RNS Number : 1836V

AGI Therapeutics plc

09 January 2012

For immediate release

Not for release, publication or distribution, in whole or in part, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction

09 January 2012

PRE-CONDITIONAL RECOMMENDED CASH OFFER

BY

ARAVIS THERAPEUTICS LIMITED

FOR

AGI THERAPEUTICS PLC

Summary

-- The boards of Aravis Therapeutics Limited ("Aravis") and AGI Therapeutics plc ("AGI") are pleased to announce that they have reached agreement on the terms of a recommended cash offer by Aravis for the entire issued and to be issued share capital of AGI.

-- AGI is a specialty pharmaceutical company which is focused on the development and commercialisation of differentiated specialty drug products to treat un-met medical needs, including conditions which qualify for orphan drug status.

-- Under the terms of the Offer, AGI Shareholders will be entitled to receive US$0.1171 in cash for each AGI Share they own.

-- AGI Shareholders will be able to elect to receive their entire cash consideration pursuant to the Offer either in US Dollars or Euro. The Euro cash amount payable will be determined based on the prevailing US$/EUR exchange rate either on the day the Offer becomes or is declared wholly unconditional or if valid acceptances are received after that date then on the day their cash consideration is converted into Euro.

-- The Offer values the entire issued and to be issued share capital of AGI at approximately US$8.4 million (EUR6.6 million).

-- Based on the closing US$/EUR exchange rate of 1.2776 on 06 January 2012, being the latest practicable date prior to the date of this announcement, the Offer values each AGI Share at EUR0.0917. This represents:

-- a premium of approximately 67 per cent. to the Closing Price of EUR0.055 per AGI Share on 06 January 2012, being the last Business Day prior to the date of this announcement;

-- a premium of approximately 130 per cent. to the average daily Closing Price per AGI Share for the three months up to the last Business Day prior to the date of this announcement, being EUR0.040;

-- a premium of approximately 137 per cent. to the average daily Closing Price per AGI Share for the six months up to the last Business Day prior to the date of this announcement, being EUR0.039.

-- The making of the Offer is conditional upon satisfaction of the pre-condition set out in Appendix III to this announcement. The pre-condition requires Aravis to receive by 12 noon on the date of this announcement irrevocable undertakings in a form satisfactory to Aravis from AGI Directors, and the AGI Investors to accept (or procure the acceptance of) the Offer in respect of 31,359,118 AGI Shares and, to the extent exercised, 4,200,000 "in the money" AGI Share Options, in aggregate representing approximately 49.6 per cent. of the entire issued and to be issued share capital of AGI at the date of this announcement.

-- The Board of AGI, which has been so advised by Davy Corporate Finance, considers the terms of the Offer to be fair and reasonable. In providing its advice, Davy has taken into account the commercial assessments of the Board of AGI.

-- Accordingly, the Board of AGI unanimously recommends that AGI Shareholders accept the Offer.

Commenting on the Offer, Ronan Lambe, Non-Executive Chairman of AGI, said:

"AGI is pleased to announce the Offer, which has been unanimously recommended by our Board of Directors. We believe the Offer represents an attractive premium relative to our recent share price trading history and when the Offer is considered alongside other alternatives the Offer represents the best outcome for Shareholders".

This summary should be read in conjunction with the full text of the following announcement and appendices.

The Offer will be subject to the conditions and further terms set out in Appendix I of this announcement, which will also be set out in the Offer Document and the Form of Acceptance. Appendix II contains the bases of calculation and sources of certain information contained in this announcement. Appendix III sets out the pre-condition to the making of the Offer. Appendix IV sets out definitions of certain terms used in this announcement (including in this summary).

Davy Corporate Finance is acting as financial adviser to AGI. Beauchamps Solicitors are acting as legal adviser to AGI.

Goodbody Corporate Finance is acting as financial adviser to the Aravis Group. A&L Goodbody is acting as Irish legal adviser and Burke, Warren, MacKay & Serritella, P.C is acting as US legal adviser to the Aravis Group.

Enquiries:

topinfo
30/11/2011
19:43
Robward

I would normally not get that excited but holding a share making new monthly
highs in this market is gold dust, the rest i've got are doing the opposite.

kinghorm23
30/11/2011
17:52
all the smartest people talk to themselves ;)
looks like some action soon here i think (& hope)
gla
m

maurillac
30/11/2011
17:48
I'm enjoying watching you post to yourself lol
robward
30/11/2011
17:36
Another high and and no poster here except me :-))

Looking good for 5-6p soon

kinghorm23
30/11/2011
13:24
Sell 100k 4.63p, max buy online 1500 shares.
kinghorm23
30/11/2011
10:59
Baffled how a 150k buy cannot move it let alone the 15k one :-))
kinghorm23
30/11/2011
09:34
3 v 1 now, mm switched to bid on 10k buy.

Could be heading for 5.25p offer if last mm gets took out.

kinghorm23
30/11/2011
08:26
Can sell 100,000 today at 4.62p mid price cannot buy 10k online.

Spikey spikey time if buyers show.

kinghorm23
29/11/2011
16:02
Gaining momentum now at last.
kinghorm23
29/11/2011
14:29
And 4.5p mid price to sell online.
kinghorm23
29/11/2011
14:28
Just no stock around.

In this market Agi chart is quite amazing, you will be lucky to find 5
small cap stocks hitting 4 month highs.

Could get back to 8p steadily.

kinghorm23
29/11/2011
13:32
Distinct increase in volume last couple of days - although still small amount traded. Last time anyone sold any of this was 2 weeks ago. The spread is very wide which means the MMs are making money on these small trades, I guess they're happy for buys to trickle in for the time being. Once they run out of stock it should go up very quickly.

Bob

bobbarker
29/11/2011
12:47
Buys full offer but no movement on L2 ?

Wonder why they wont let it go ?

kinghorm23
29/11/2011
11:25
yes they were paying 4.28p last week when i tried a dummy trade
looks interesting
m

maurillac
29/11/2011
11:15
Reckon there might be some good news coming here, you cannot buy a bean
online and it's only 10k max NMS.

I'm getting 4.28p to sell my holding which is over the mid and for size.

Somebody happy to pay 5p for size now and again, what do they know because
that price needs a 20% rise just to break even.

Why do i think this might spike even in this poor market, just looks good
and when mm let it go you might see if there's anybody left here still holding.

kinghorm23
28/11/2011
16:16
100k buy pays 5p
kinghorm23
21/11/2011
09:59
78000 buy at 5p just gone though on plus
curlly
15/11/2011
00:14
small top-up today --- need to try to catch up with Paul Johnson -- if only !
kamose
09/11/2011
17:08
AGI Therapeutics plc ('AGI')

Holding in Company


AGI was notified on the 9th November 2011 that Paul Johnson has increased his shareholding to 2,720,615 shares representing 4.04% of AGI's Issued share capital.

kamose
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older

Your Recent History

Delayed Upgrade Clock